You have read all your free articles, to continue reading subscribe to read the rest of this content.
A candidate drug developed by Umecrine Mood AB to treat premenstrual dysphoric disorder (PMDD) showed positive results during a randomized Phase I/II study. Those taking the drug called UC1010 showed a significant reduction in PMDD symptoms compared to those taking a placebo. “UC1010 has beenAlready a subscriber Login You have…
This year’s Outsourcing in Clinical Trials Nordics conference covered a range of current topics in the clinical and medical device trial industry. At the beginning of September this year, CEOs, Chief Medical Officers and Clinical Directors met in Copenhagen to discuss current matters within outAlready a subscriber Login You have…
Orexo has announced positive results from the first explorative human clinical study for its nasal epinephrine (adrenaline) rescue medication for allergic reactions, OX640. The study was a comparative bioavailability study performed in 40 healthy volunteers assessing four investigational formulatAlready a subscriber Login You have read all your free articles, to…
Genmab and AbbVie have announced topline results from the first cohort of the EPCORE NHL-1 clinical trial evaluating epcoritamab (DuoBody-CD3xCD20), an investigational subcutaneous bispecific antibody. The study cohort includes 157 patients with relapsed/refractory large B-cell lymphoma (LBCL) whAlready a subscriber Login You have read all your free articles, to continue…
